INCREASED EXPRESSION OF MUTATED BRCA2 IS ASSOCIATED WITH POOR PROGNOSIS OF PATIENTS WITH HIGH RISK PROSTATE CANCER TREATED WITH DEFINITIVE RADIOTHERAPY

被引：0
|
作者：
Iwamura, Hiromichi
Ito, Jun
Mikami, Jotaro
Ise, Kazue
Kohada, Yuki
Anan, Go
Matsushita, Mabumi
Kaiho, Yasuhiro
Ohyama, Chikara
Nakamura, Yasuhiro
Sato, Makoto
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP16-13
引用
下载
收藏
页码：E220 / E220
页数：1
相关论文
共 50 条
  • [21] Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
    Bi, Cheng-wei
    Zhang, Guo-ying
    Bai, Yu
    Zhao, Bin
    Yang, Hong
    MEDICINE, 2019, 98 (36)
  • [22] BRCA2 MUTATION WITH A DIAGNOSIS OF PROSTATE CANCER FROM HIGH RISK BREAST CANCER FAMILIES CONFERS A SUBSTANTIALLY INCREASED RISK OF CANCER RELATED MORTALITY
    Ho, Ivan
    Thorne, Heather
    Willems, Amber
    Clouston, David
    Fox, Stephen
    Li, Jason
    Bolton, Damien
    JOURNAL OF UROLOGY, 2010, 183 (04): : E837 - E837
  • [23] High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy
    Mitra, Devarati
    Horick, Nora K.
    Brackett, Diane G.
    Mouw, Kent W.
    Hornick, Jason L.
    Ferrone, Soldano
    Hong, Theodore S.
    Mamon, Harvey
    Clark, Jeffrey W.
    Parikh, Aparna R.
    Allen, Jill N.
    Ryan, David P.
    Ting, David T.
    Deshpande, Vikram
    Wo, Jennifer Y.
    ONCOLOGIST, 2019, 24 (06): : E275 - E283
  • [24] High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
    He, Li-Ru
    Liu, Meng-Zhong
    Li, Bin-Kui
    Jia, Wei-Hua
    Zhang, Ying
    Liao, Yi-Ji
    Chen, Yang-Chao
    Zhang, Lan-Jun
    Guan, Xin-Yuan
    Zeng, Yi-Xin
    Kung, Hsiang-Fu
    Xie, Dan
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) : 138 - 147
  • [25] Quality of life in prostate cancer patients treated with definitive hypofractionated radiotherapy
    Ma, J.
    Trapp, C.
    Rogowski, P.
    Schmidt-Hegemann, N.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1250 - S1251
  • [26] Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC)
    Abida, Wassim
    Campbell, David
    Patnaik, Akash
    Sautois, Brieuc
    Shapiro, Jeremy David
    Vogelzang, Nicholas J.
    Bryce, Alan Haruo
    McDermott, Raymond S.
    Ricci, Francesco
    Rowe, Julie Haewon
    Zhang, Jingsong
    Loehr, Andrea
    Despain, Darrin
    Dowson, Melanie
    Golsorkhi, Tony
    Chowdhury, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [27] High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients
    Chen, Lingxiao
    Xiong, Wei
    Qi, Lin
    He, Wei
    BMC UROLOGY, 2023, 23 (01)
  • [28] High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients
    Lingxiao Chen
    Wei Xiong
    Lin Qi
    Wei He
    BMC Urology, 23
  • [29] Increased MTHFD2 expression is associated with poor prognosis in breast cancer
    Liu, Feng
    Liu, Yang
    He, Chuan
    Tao, Li
    He, Xiaoguang
    Song, Hongtao
    Zhang, Guoqiang
    TUMOR BIOLOGY, 2014, 35 (09) : 8685 - 8690
  • [30] High expression of GMII is associated with poor prognosis of gastric cancer patients
    Zhu, Shasha
    Li, Yao
    Xiao, Wei
    Yang, Yaying
    ONCOTARGETS AND THERAPY, 2019, 12 : 4379 - 4389
12345